| 000 | 01460 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513072523.0 | ||
| 264 | 0 | _c19930805 | |
| 008 | 199308s 0 0 eng d | ||
| 022 | _a0098-6577 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMoriniere, P | |
| 245 | 0 | 0 |
_aImprovement of severe secondary hyperparathyroidism in dialysis patients by intravenous 1 alpha(OH) vitamin D3, oral CaCO3 and low dialysate calcium. _h[electronic resource] |
| 260 |
_bKidney international. Supplement _cJun 1993 |
||
| 300 |
_aS121-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCalcium _xanalysis |
| 650 | 0 | 4 |
_aCalcium Carbonate _xadministration & dosage |
| 650 | 0 | 4 |
_aDialysis Solutions _xchemistry |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxycholecalciferols _xadministration & dosage |
| 650 | 0 | 4 |
_aHyperparathyroidism, Secondary _xtherapy |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPhosphates _xblood |
| 650 | 0 | 4 |
_aRenal Dialysis _xadverse effects |
| 700 | 1 | _ael Esper, N | |
| 700 | 1 | _aViron, B | |
| 700 | 1 | _aJudith, D | |
| 700 | 1 | _aBourgeon, B | |
| 700 | 1 | _aFarquet, C | |
| 700 | 1 | _aGheerbrant, J | |
| 700 | 1 | _aChapuy, M | |
| 700 | 1 | _aVan Orshoven, A | |
| 700 | 1 | _aPamphile, R | |
| 773 | 0 |
_tKidney international. Supplement _gvol. 41 _gp. S121-4 |
|
| 999 |
_c8320183 _d8320183 |
||